Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy
Kirsten A. White, Kate Connor, Maxime Meylan, Antoine Bougoüin, Manuela Salvucci, Franck Bielle, Alice C. O’Farrell, Kieron J. Sweeney, Lihong Weng, Gabriele Bergers, Patrick Dicker, David M. Ashley, Eric Lipp, Justin Low, Junfei Zhao, Pengbo Wen, Robert M. Prins, Maïté Verreault, Ahmed Idbaïh, Antara Biswas, Jochen H.M. Prehn, Diether Lambrechts, Ingrid Arijs, Francesca Lodi, Gonca Dilcan, Martine L.M. Lamfers, Sieger Leenstra, Federica Fabro, Ioannis Ntafoulis, Johan M. Kros, Jane Cryan, Francesca M. Brett, Emie Quissac, Alan Beausang, Steve MacNally, Philip J. O’Halloran, James Clerkin, Orna Bacon, Andreas Kremer, Romain Tching Chi Yen, Frederick S. Varn, Roel G.W. Verhaak, Catherine Sautès‐Fridman, Wolf H. Fridman, Annette T. Byrne
Topics & Concepts
ImmunotherapyMedicineTumor microenvironmentImmune systemGliomaImmune checkpointCancer researchPopulationImmunologyOncologyEnvironmental healthGlioma Diagnosis and TreatmentFerroptosis and cancer prognosisCancer Immunotherapy and Biomarkers